Report Code: A01352
The global Proteomics Market Size was valued at $23,654.34 million in 2021, and is projected to reach $98,051.83 million by 2031, growing at a CAGR of 15.2% from 2022 to 2031. Proteomics is defined as the branch of biotechnology concerned with applying the techniques of molecular biology, biochemistry, and genetics to analyze the structure, function, and interactions of the proteins produced by the genes of a particular cell, tissue, or organism, with organizing the information in databases, and with applications of the data (as in medicine or biology). Some of the common types of proteomics are classified into various categories such as structural proteomics, expression proteomics, and functional proteomics. Technologies employed in structural proteomics are X-ray crystallography and nuclear magnetic resonance spectroscopy. Technologies such as 2D-PAGE and mass spectrometry are used in expression proteomics, whereas, the affinity chromatography technique is used to isolate sub-proteomes.
The overall impact of COVID-19 remains positive on the proteomics market, owing to fact that the pandemic significantly increased demand for proteomics services, having a considerable impact on market expansion despite generating disruptions in a number of different industries. New trial models or strategies utilizing cutting-edge mass spectrometers for high-quality results kept gaining popularity, notably among CROs. For instance, in 2020, the use of cutting-edge mass spectrometer technologies enabled the discovery of proteins specific to COVID-19. These characteristics have given the proteomics sector good growth prospects.
The market was analyzed qualitatively and quantitatively from 2018-2020. Most of the growth during this period was derived from the Asia-Pacific owing to the rise in prevalence of cancer and chronic diseases and the increase in interest of researchers to utilize proteomics in disease diagnosis & treatment, improving health awareness, rising disposable incomes, as well as the well-established presence of domestic companies in the region.
Proteomic technologies possess high potential in the search for new clinical biomarkers for early detection and diagnosis of cancer and other diseases as well as the discovery of new therapeutic targets from accessible bio-specimens, creates an opportunity for the proteomics market. The rise in technological advancements in the field of proteomics is expected to boost the growth of the market. For instance, in June 2022, Bruker Corporation launched a new product for the evolution of the revolutionary 4D Multiomics timsTOF platform with the launch of the new timsTOF HT system. The timsTOF HT includes a novel 4th-generation TIMS (trapped ion mobility separation) XR cell and 14bit digitizer for even greater dynamic range, enhanced peptide coverage, and more accurate quantitation, particularly in unbiased 4D plasma and tissue proteomics and epiproteomics.
The Proteomics Market Growth is expected to be driven by the rise in the demand for personalized medicines & the surge in the number of advanced diagnostics tools in targeted disease diagnosis & treatment. Furthermore, increasing focus on product usage in drug designing, biomarker discoveries, and clinical diagnostics for the diagnosis and treatment of diseases, and the rise in the prevalence of cancer and chronic diseases.
Moreover, the increase in the number of R&D activities in the field of proteomics, enhanced healthcare services, and significant investments by the government to improve healthcare infrastructure has become a vital tool for small and large businesses globally, due to the rise in preference for personalized medicines for targeted disease. This is attributed to further support market growth. The demand for proteomics is not only limited to developed countries but is also being witnessed in developing countries, such as China, Brazil, and India, which fuel the growth of the Proteomics Market Size.
Advances in proteomic technologies have made an important contribution to the development of personalized medicine by facilitating the detection of protein biomarkers, proteomics-based molecular diagnostics, as well as protein biochips and pharmaco-proteomics. For instance, on 19 February 2020, NantHealth and NantOmics announce the GPS cancer platform, which may improve the clinical trial design of combination strategies by identifying previously unrecognized cancer type-specific associations between immunoregulatory molecules and genomic mutations. This, high cost associated with proteomics components such as (instruments, reagents, and other products) is anticipated to hamper the growth of the Proteomics Market Forecast period.
The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The disease has forced several industries to shut their doors temporarily, including several sub-domains of health care. The global proteomics market experienced a slight increase in 2020 as the pandemic significantly increased demand for proteomics services. In addition, the use of cutting-edge mass spectrometer technologies enabled the discovery of proteins specific to COVID-19. However, the market is anticipated to witness steady growth in 2021 and will grow at a significant CAGR during the forecast period for the proteomics market. This is attributed to the increase in the adoption of the use of personalized medicine for the treatment of targeted diseases during COVID-19 as well as an increase in the technological advancement in the field of proteomics.
The global proteomics market is segmented based on component, application, and region. Based on components, the market is categorized into reagents, instruments, and services. The reagents segment is further sub-segmented into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is sub-segmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry. Likewise, the chromatography segment is sub-classified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography.
The applications covered in the study include drug discovery, disease diagnosis, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By component: based on component, the market is segmented into reagents, instruments, and others. The reagent segment has the largest Proteomics Market Share in 2021 and is expected to remain dominant throughout the forecast period, owing to reagents are widely used in academic research facilities and research labs to analyze a variety of biological samples, which increases the demand for reagents and hence, propels the growth of the market.
By application: proteomics market is segregated into drug discovery, disease diagnosis, and others. The drug discovery segment dominated the global market in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to advancements in proteomics have helped researchers to formulate medications that are personalized for different individuals to achieve better effectiveness and fewer side effects.
By region: The proteomics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the proteomics market in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major players, such as Agilent Technologies Inc, Bio-Rad Laboratories, Bruker Corporation, Danaher Corporation, GE Healthcare, and Thermo Fisher Scientific, and advancement in manufacturing technology of proteomics in the region drive the growth of the market. In addition, the surge in investments in the development of structure-based drug design, rising growth in omics research, and rise in the demand for high-quality research tools for data reproducibility, increases the demand for proteomics in the region, which is drives the growth of market.
Furthermore, the presence of well-established healthcare infrastructure and a rise in the adoption rate of personalized medicines are expected to drive market growth. Furthermore, product launches, mergers, collaborations, and acquisitions adopted by the region's key players boost the market's growth. For instance, in January 2022, Bruker Corporation collaborated with PreOmics. PreOmics offers unique technologies, advanced automation solutions, and high-performance consumables for the homogenization, enrichment, and sample preparation of biopsy, tissue, cell line, and plasma samples in unbiased, deep proteomics for biopharma and clinical use.
Asia-Pacific is expected to grow at the highest rate during the forecast period. The Proteomics Industry growth in this region is attributable to the presence of pharmaceutical companies in the region as well as the rise in the geriatric population of the countries, such as China and India. Moreover, the rise in demand for personalized medicine increases demand for drug discovery, and advances in the biotechnology sector, drive the growth of the market. Furthermore, the Asia-Pacific region exhibits the largest medicine supply and the largest pharmaceutical industry with the availability of raw materials and technologically advanced medical devices in abundance, which manufacturers of proteomics-based products can easily access. This, in turn, drives the growth of the market.
Asia-Pacific offers profitable opportunities for key players operating in the proteomics market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as the well-established presence of domestic companies in the region. In addition, increased technological innovations and heavy funding by government and private organizations, and increased investment by companies in R&D activities are expected to provide great opportunities for the growth of the market in this region.
Competitive analysis and profiles of the major players in the proteomics market, such as Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., Merck KgaA, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation are provided in this report. There are some important players in the market such as Bruker Corporation and others. Major players have adopted product launch, product expansion, and acquisition as key developmental strategies to improve the product portfolio of the proteomics market.
Some examples of product launches in the market
Product launch in the market
In August 2022, Bruker Corporation launched the new nanoElute 2 nano-LC, of MetaboScape and TASQ 2023 software supporting fluxomics, and of latest advances in PaSER intelligent acquisition to enhance research in protein-protein interactions (PPIs) and metaproteomics applications.
Collaboration in the market
In March 2021, Thermo Fisher Scientific, the world leader in serving science, collaborated with Protein Metrics, a developer of world-class software tools for protein characterization, have entered into a non-exclusive co-marketing agreement to provide advanced mass spectrometry data processing and analysis capabilities to drive innovation across the full spectrum of biopharmaceutical and proteomics applications, from research and development to quality control.
Proteomics Market Report Highlights
|Market Size By 2031||USD 98.1 billion|
|Growth Rate||CAGR of 15.2%|
|Forecast period||2021 - 2031|
|By Component|| |
|By Application|| |
|By Region|| |
|Key Market Players||Thermo Fisher Scientific Inc., Waters Corporation, Danaher Corporation, Bio-Rad Laboratories Inc, Horiba Ltd., Agilent Technologies Inc., Merck KGaA, Li-Cor Inc, Perkin Elmer Inc, Bruker Corporation|
Loading Table Of Content...
This section provides opinions of top-level CXOs of the proteomics industry. In accordance with several interviews conducted, the global proteomics market is expected to witness significant growth in the future. The market has piqued the interest of the healthcare industry, as proteomics helps to bridge the gap between the understanding of genome expression and cellular behavior as well as helps in increasing the popularity of personalized medicines.
According to the perspectives of CXOs of leading proteomics companies, the need for personalized medicines is anticipated to increase considerably, which is expected to fuel the growth of the global market. As per the CXOs, the use of proteomics is the highest in the North American region, followed by Europe and Asia-Pacific, owing to heavy R&D expenditure and increased research funding from various organizations, such as National Institutes of Health (NIH).
The CXOs further added that North America is expected to remain dominant during the forecast period. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to increase in disposable income of populace, improvement in healthcare infrastructure, and rise in demand for advanced technologies, such as proteomics
A. The upcoming trends of Proteomics Market are rise in focus of key players toward product development, surge in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are expected to drive the market growth.
A. The base year for the report is 2021
A. North America is the largest regional market for Proteomics
A. $98,051.83 million is the estimated industry size of Proteomics in 2031
A. Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation are the top companies to hold the market share in Proteomics
A. Yes, Proteomics Market companies are profiled in the report
A. No, there is no value chain analysis provided in the Proteomics Market report
A. The forecast period in the report is from 2022 to 2031
Start reading instantly.
This Report and over 71,215+ more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers